This inventor holds 2 USPTO granted patents. Top assignees: Shionogi Company Limited, Other. Active years: 2006-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,001 
2 out of 834,513 Years Active: 2006-2008
Title: The Innovative Contributions of Hisashi Iizasa
Introduction: Hisashi Iizasa, an accomplished inventor based in Kanazawa, Japan, has made significant strides in the field of molecular biology and immunology. With a total of two patents to his name, his work primarily focuses on the interactions of chemokine receptors and their implications for therapeutic advancements.
Latest Patents: Hisashi Iizasa's latest patents revolve around the Mouse CXC chemokine receptor. These inventions pertain to a DNA encoding a polypeptide, which includes an entire sequence of the amino acid sequence as presented by SEQ ID NO: 2, or a partial sequence thereof. The polypeptide described in the patents exhibits the ability to bind to murine PBSF/SDF-1, offering potential pathways for screening inhibitors for AIDS onset or HIV-1 infection. The innovations introduce a novel murine CXC chemokine receptor gene, alongside methods for screening therapeutic agents for AIDS and understanding the functional mechanism behind HIV-1 infection.
Career Highlights: Hisashi Iizasa has contributed to the scientific community through his innovative work while aligning with reputable companies, including Shionogi & Company Limited. His research and inventions have not only advanced scientific understanding but have also brought potential solutions to pressing medical challenges.
Collaborations: Throughout his career, Iizasa has collaborated with notable figures in the field, such as Tadamitsu Kishimoto and Takashi Nagasawa. These partnerships have fostered a collaborative environment that encourages the sharing of ideas and expertise, significantly enhancing the impact of his work.
Conclusion: Hisashi Iizasa stands out as an inventive force in the realm of molecular biology, with his patents opening new avenues for AIDS research and treatment. His contributions to the understanding of chemokine receptors play a vital role in the ongoing fight against HIV-1 infection, marking him as a prominent figure in contemporary scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile